Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC

Clinical trial NCT05771896 · WITHDRAWN

Trial details

NCT number: NCT05771896
Sponsor: GenesisCare USA
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2023-09-01
Primary completion: 2028-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.